Percentage of patients with a new ADR that were given written ADR information at discharge AND a copy was communicated to the primary care clinician. Written ADR information should include, as a minimum, the following: • generic and brand names of the medicine(s) involved • reaction(s) that occurred, described in lay terms e.g. rash, lip swelling, kidney failure • advice about how to minimise the possibility of a future ADR to that medicine. A copy of the information given to the patient should be included in the medical record, or explicit documentation made in the medical record that information was given. A copy is communicated to the primary care clinician means a copy of the plan is sent to the community-based health practitioner nominated by the patient, or included in the discharge summary or discharge letter. Such communication should be explicitly documented in the medical record.

Number of patients with a new ADR that were given written ADR information at discharge AND a copy was communicated to the primary care clinician

Number of patients with a new ADR in sample

None

Medication charts, medical records and discharge documentation

Recommended for local quality improvement processes. Not regularly reported at national level.

Australian Commission on Safety and Quality in Health Care and NSW Therapeutic Advisory Group Inc. (2014), National Quality Use of Medicines Indicators for Australian Hospitals. ACSQHC, Sydney www.safetyandquality.gov.au/sites/default/files/migrated/SAQ127NationalQUMIndicatorsV14-FINAL-D14-39602.pdf page 92